Memorial Sloan Kettering researchers report advancements in AI governance, biomarker analysis, and language models for improved cancer care.
Key Details
- 1MSK implemented governance covering 26 AI models, two ambient pilots, and 33 nomograms, demonstrating scalable AI oversight.
- 2AI tool EAGLE analyzed over 8,000 lung cancer slides, reducing molecular testing by over 40% while maintaining standards.
- 3A cancer-trained LLM ('Woollie') was built from 40,000+ radiology reports; achieved predictive scores of 97 (MSK) and 88 (UCSF) overall.
- 4Study on 118 nonagenarians showed lung cancer surgery can be safe and effective, with no patients dying within 90 days.
- 5Drug combination shown to induce mutation (MMRd) in colorectal tumors, potentially sensitizing resistant cancers to immunotherapy, but no clinical responses observed yet.
Why It Matters
Robust governance and real-world validation are crucial for integrating AI into oncology workflows. New computational tools, especially those leveraging radiology and pathology data, show promise for improving clinical decision-making and operational efficiency in precision cancer care.
Source
EurekAlert
Related News
•EurekAlert
AI Predicts Risks for Outpatient Stem Cell Therapy in Myeloma
Researchers use machine learning to predict adverse events during stem cell therapy for multiple myeloma, improving outpatient safety.
•EurekAlert
USC Unveils Joint Biomedical Engineering Department Bridging Medicine, Engineering, and Imaging
USC's medical and engineering schools launch a joint biomedical engineering department to accelerate interdisciplinary research and innovation, including imaging and AI.
•EurekAlert
AI-Enhanced CT Heart Fat Measurement Boosts Cardiovascular Risk Prediction
AI-derived measurement of heart fat from CT scans significantly improves long-term cardiovascular disease risk prediction.